Symbollon begins evaluating fibrocystic breast disease therapeutic in the clinic Oct. 28, 1998 No Comments
Dainippon's aldose reductase inhibitor in phase II in Japan; European development now planned Oct. 27, 1998 No Comments
Positive phase II results obtained for Allelix's recombinant hPTH in osteoporosis Oct. 26, 1998 No Comments
Phase III trial of Nutropin Depot successfully completed; NDA filing slated for 1999 Oct. 23, 1998 No Comments
RSS